KAYLA WALLS: Open Payments
NPI 1619337268 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 28 payments from 9 companies in 2025. Trend: 2023 $566 · 2024 $295 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 15 | $177 |
| Gilead Sciences, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| ABBVIE INC. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| GENZYME CORPORATION | 1 | $15 |
Products named: IBSRELA, VOQUEZNA, ENTYVIO, REZDIFFRA, TREMFYA, IQIRVO, LINZESS, DUPIXENT.
Industry payments across AL — which companies pay providers there.
